India Showcases Indigenous Medical Innovation as ICMR Hands Over Three Technologies to Industry

Date:

Share post:

India marked a major milestone in healthcare innovation at the National Technology Day 2026 programme ‘विज्ञान–Tech’, where the Indian Council of Medical Research transferred three indigenous medical technologies to industry partners for wider public use. The initiative reflects the growing emphasis on translating scientific research into accessible healthcare solutions under India’s innovation-driven development agenda.

The event brought together 14 scientific ministries and departments to showcase the country’s advancements in science, healthcare, biotechnology, and technology-led public welfare. The technology transfer by ICMR is expected to strengthen industry-academia collaboration while accelerating the commercialisation of affordable, homegrown medical innovations.

Officials highlighted that such initiatives play a crucial role in reducing dependence on imported healthcare technologies and boosting the ‘Make in India’ vision in the medical sector. The programme also underscored India’s expanding capabilities in research, innovation, and indigenous technology development aimed at improving healthcare accessibility and strengthening the nation’s scientific ecosystem.

Written by : Sharon Bose & Arundhuti Chatterjee

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...